REJUTRIA

Serial Number 90245441
606

Registration Progress

Application Filed
Oct 9, 2020
Under Examination
Jun 1, 2021
Approved for Publication
Apr 6, 2021
Published for Opposition
Apr 6, 2021
Registered

Trademark Image

REJUTRIA

Basic Information

Serial Number
90245441
Filing Date
October 9, 2020
Published for Opposition
April 6, 2021
Abandonment Date
July 8, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 8, 2024
Classes
005

Rights Holder

Biohaven Therapeutics Ltd.

99
Address
Ritter House, P.O. Box 173
Road Town, Tortola VG1110
VG

Ownership History

Biohaven Therapeutics Ltd.

Original Applicant
99
New Haven, CT

Biohaven Therapeutics Ltd.

Owner at Publication
99
Road Town, Tortola VG

Legal Representation

Attorney
Monica Riva Talley

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

34 events
Date Code Type Description Documents
Jul 12, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 8, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 27, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 27, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 19, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 19, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 17, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 17, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 7, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 5, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 5, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 5, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 24, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 22, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 22, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 22, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 24, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 20, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 20, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
May 20, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 1, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 29, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 29, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 29, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 1, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 6, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 6, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 17, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 27, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 27, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 24, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 13, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, for the treatment of neuroinflammatory and neurodegenerative diseases and disorders, and for neuroprotection

Classification

International Classes
005